dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Meeting Oct. 31st

Sotsiaalministeerium · 19. september 2018
Viit
1.4-4/2953-1
Registreeritud
19. september 2018
Dokumendi liik
Sissetulev kiri
Adressaat
CME-EA
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2018
Vastutaja
Vootele Veldre (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervisesüsteemi arendamise osakond)

Failid

  • 📎AnfahrtskizzeBAEK2010Gross.jpg
  • 📎Cover letter- position paper-f.pdf1350 KB
  • 📎E-kiri.pdf338 KB
  • 📎Framework for industry engagement and quality principles for industry provided medical education in Europe.pdf
  • 📎Position Paper on Accreditation of CME-CPD and Independence-f.pdf580 KB

Sisu (failidest)

Dear  Colleague,     We  are  inviting  you  to  join  an  initiative  to  protect  the  integrity  of  specialist   physicians’  CME/CPD.  Recent  publications  have  attempted  to  promote  the   role  of  industry  in  the  provision  of  CME  for  specialists.  We  believe  this   should  be  resisted.     Following  medical  studies  and  specialty  training  working  as  a  specialist   comprises  the  longest  time  period  in  a  physician’s  life.  Hence  continuing   education  and  professional  development  are  cornerstones  to  achieve   maintenance  and  adaptation  of  professional  competence  to  contemporary   requirements.   Physicians  have  committed  themselves  to  focus  in  this  process  on  the  best   interest  of  their  patients,  and  in  particular  to  make  their  judgements  and   recommendations  independent  from  third  party  interests.   With  regard  to  Continuing  Medical  Education  (CME)-­‐  Continuing   Professional  Development  (CPD)  there  is  an  on-­‐going  discussion  on  how  to   preserve  independence  of  CME-­‐CPD  from  commercial  interests.     Unlike  the  situation  in  North  America,  where  two  organisations  cover  the   whole  subcontinent,  the  situation  in  Europe  is  characterised  by  greater   fragmentation.  Thus,  the  newly  formed  association  of  independent   European  accreditors  (CME-­‐EA)  aims  to  promote  a  European  consensus  on   independence  of  CME-­‐CPD,  endorsed  by  all  organisations  involved  in   defining  the  framework  for  CME-­‐CPD  in  their  country,  to  demonstrate  that,   although  working  under  diverse  legal  frameworks,  physicians  in  Europe  all   still  belong  to  one  profession,  sharing  the  same  principles  and  values.   For  this  purpose  CME-­‐EA  has  drafted  a  position  paper  on  independence  in   CME-­‐CPD,  to  be  published  in  the  major  journal  dealing  with  CME-­‐CPD   issues,  and  we  would  like  to  ask  you  to  consider  becoming  a  co-­‐author  of   this  publication  in  order  to  ensure  the  widest  possible  consensus.   Please  consider  this  a  draft  for  discussion,  and  feel  free  to  enter  your   comments  as  well  as  bibliography  relevant  to  your  country.   Having  received  your  contributions  and/or  comments,  we  intend  to   convene  all  contributors  and  discuss  the  final  version  of  the  paper  in  a  live   meeting  later  the  year.   CME-­‐EA    e.V.,  c/o  EBAC  GmbH,  Schanzenstr.  36,  Geb.  31a,  D-­‐51063  Koeln         Let  your  voice  be  heard!       Yours             Fabiola  de  Andrade,  MA                                                      Prof.  Reinhard  Griebenow,  MD,  PhD   Chair,  CME-­‐EA                                                                                          Vice-­‐chair,  CME-­‐EA           CME-­‐EA    e.V.,  c/o  EBAC  GmbH,  Schanzenstr.  36,  Geb.  31a,  D-­‐51063  Koeln Dear Dr. Jesse, recent activities from industry to become recognised as providers in accredited CME-CPD need a joint response from European organisations involved in accreditation of CME-CPD on the national as well as international level. CME-EA has started to facilitate and moderate this process by preparing a draft position paper, and would like to invite your organisation to contribute as co-author to the final version, to be published in national as well as international media (please see attachments to this invitation). Thus, on behalf of CME-EA we would like to invite you to a live meeting to take place at the premises of the German Medical Association on October 31st, 2018, 11am-4pm Bundesärztekammer Herbert–Lewin-Platz 1 10623 Berlin (near S-train station “Tiergarten”) The invitation primarily reaches out to accreditation bodies. In case that CME accreditation has not been implemented on the national level, organisations in charge of defining professional standards have been invited. If this should not relate to your organisation, we would be grateful, if you could pass the invitation to those in charge or most interested in this matter. Looking forward to meet you in Berlin we remain With best regards Fabiola de Andrade Prof. Reinhard Griebenow,MD Chair, CME-EA Vice-chair, CME-EA P.S. Please note: cost for travel and accommodation have to be covered by your organisation, a buffet lunch will be provided. For planning purposes we kindly ask you to let us know in advance how many members of your organisation are going to attend. Position paper Independent Continuing Medical Education (CME)/Continuing Professional Development (CPD) means at first independent information Authors: European accreditation bodies (national/international) Physicians have committed themselves to always act in the best interest of their patients (1), this includes their approach to continuing medical education (CME) as well as continuing professional development (CPD) which are cornerstones for the maintenance of professional competence (MOC). For many years professional codes, and in some countries also the (professional) law, have defined that CME/CPD must be independent of commercial interests (1, EU-national). Over the last few decades numerous national bodies have introduced CME/CPD accreditation to ensure that the planning and conduct of CME/CPD follows a set of defined standards, with independence of commercial interests as one of the leading principles (EU-national, 2, 3). In Europe, this is augmented by an additional type of accreditor, the European international accreditor. These accreditors include members of CME-EA, EACCME and other organisations and are devoted to accreditation of CME/CPD activities in Europe that have primarily international attendance. However, accreditation has little value in and on its own, it is almost entirely dependent on having clear and transparent definitions, rigorous application of appropriate principles and rules, and being in the position to enforce its own standards. With regard to enforcement , only a few European national accreditation systems are officially legitimated by national jurisdictions (e.g. DE, AT, IT). This enables the accreditor to impose accreditation on all providers nationwide (but vice-versa also imposing legal liability on the accreditor). But still many accreditors in Europe (including all European international accreditors) are institutions based on civil law, and thus lack official legitimation. Despite the sometimes uncertain legal basis CME/CPD accreditation still serves as an important component of quality assurance in medicine. Accreditation safeguards the credibility of the medical profession in one of the most important areas in medicine, i.e. maintenance of our intellectual basis in medical decision-making by life-long learning. Thus, irrespective of the variable legal status, accreditors will only be able to convince the (medical) public, and prove their legitimacy by comprehensible and rigorous application of their transparent principles and rules. All major accreditation systems grant accreditation prior to the start of the CME/CPD activity. This implies that accreditation relies on professional honesty, and self-commitment of the medical professionals involved in delivery of CME/CPD, to align their presentations with the principles and rules as outlined by the accreditor. There are several key principles in medical education to be followed by providers (which should also be used by participants to evaluate a given CME/CPD activity): It all starts with independence of information itself as well as independence of interpretation of information in the appropriate clinical context. Other criteria like educational efficacy of a CME/CPD activity are of secondary importance in light of the fundamental bias introduced by use of framed information in life- long learning. Fully transparent and timely provision of data can obviously collide with the commercial interests of industry (4, 5, 6), as driven by the market economy’s framework set by governments in most developed countries. This limitation weighs even more in the light of the fact that currently about 80% of all trial patients are in clinical trials sponsored by industry (7). Whilst the development and provision of drugs and devices continues to follow the fundamental principles of a market economy with its inbuilt difficulties of accessing information, then if we were to accept industry as a provider of accredited CME/CPD, as recently proposed in the Journal (8), then we would open the door for the introduction of an inevitable bias in CME/CPD. It is for this reason that major accreditors have recently reiterated in a global consensus document that “the content, as well as persons and organizations in control of the content, of the accredited CME/CPD activity is developed/selected independently, with no influence, control or involvement from a commercial interest...” (9). Many accreditors go one step further by defining the details of communication to participants to avoid any misperceptions with regard to promotion (10, EU-national), in particular in sponsored CME/CPD. Accreditors are well aware that in CME/CPD there are further threats to independent alignment of evidence with current strategies in diagnosis and treatment of particular conditions (interpretation), and discussion on how to apply evidence in the individual patient (implementation): - This includes a long list of (potential conflicts of) interests, including issues related to career development and/or welfare of individuals involved in planning and delivery of CME, but also institutional interests e.g. of hospital owners, insurance companies etc. Thus, fully transparent communication of interests to participants in CME/CPD as well as management of the conflicts of interest are indispensable supportive strategies in planning and delivery of independent CME/CPD, but they can never outweigh the negative effects of information compromised by commercial interests. This also applies to the principles of evidence based medicine, whose practice has been further facilitated by development of elaborate methods for post-processing of information to design tools to support clinical decision- making by recommendations based on grading of the strength of evidence (11), or by provision of systematic reviews and meta-analyses (12). Major accreditors recommend the systematic use of these tools in the provision of accredited CME/CPD (EU-national, -international). However, the value of such tools also critically depends on timely and complete availability of data to obtain a realistic estimate of benefit-risk ratios of diagnostic and/or therapeutic interventions. - CME/CPD should always be designed to help participants to close gaps in knowledge and/or professional performance. The underlying gap analysis as well as definition of “learning objectives” mark another area, in which commercial interests should never be involved to avoid direct agenda setting by industry, although accreditors are well aware that indirect agenda setting currently occurs by allocation of sponsoring: Evidence is available that CME with industry involvement has a narrower range of topics and more product-related content than CME without direct industry involvement even when funding is unrestricted (13). The primary importance of independence in accreditation should not override the consideration of the role of different educational formats for the delivery of effective CME/CPD. Although overall educational quality may be considered as satisfactory (EU- national, -international), accreditors have always wanted to stimulate improvement, as demonstrated by initiatives to stimulate providers to further develop their educational formats (EU-national, -international). CME/CPD accreditation has been designed to mark the difference between independent, strictly evidence based CME/CPD and interest driven CME/CPD. If there were to be no differences in requirements for independence any more, accreditation alone will not be able to resolve the issue and may be seen as no longer needed. In certain jurisdictions (Germany, 14) commercially driven CME/CPD may also be considered as providing inadequate independence in influencing opinion formation, and decision- making. This mixing up of CME/CPD with commercial interests may introduce further difficulties with differentiating medical education from advertising. Accreditation of CME/CPD currently serves several different purposes, but its fate will be decided by whether it can retain its ability to differentiate independent CME/CPD from provision of commercially framed information. References 1. World Medical Association Declaration of Geneva, accessed on Jan. 18th, 2018: https://www.wma.net/policies- post/wma-declaration-of-geneva/ 2. ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities Accessed on Jan. 18th, 2018: http://www.accme.org/requirements/accreditation- requirements-cme-providers/standards-for-commercial- support 3. National Standard for Support of Accredited CPD Activities Accessed on Jan. 18th, 2018: http://www.royalcollege.ca/rcsite/cpd/providers/tools- resources-accredited-cpd-providers/national-standard- accredited-cpd-activities-e 4. Köhler M, Haag S, Biester K, et al. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. Bmj. 2015;350:h796. 5. Anderson ML, Chiswell K, Peterson ED, et al. Compliance with results reporting at clinical trials.gov. N Engl J Med. 2015;372:1031–1039. 6. European Medicines Agency: Clinical Trial Regulation Accessed on Jan. 18th, 2018: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regu lation/general/general_content_000629.jsp 7. Flacco ME, Manzoli L, Boccia S, et al. Head-to-head rando- mized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiology. 2015;68:811–820. 8. Tamara Allen, Nina Donde, Eva Hofstädter-Thalmann, Sandra Keijser, Veronique Moy, Jean-Jacques Murama & Thomas Kellner (2017) Framework for industry engagement and quality principles for industry-provided medical education in Europe, Journal of European CME, 6:1, 1348876, DOI: 10.1080/21614083.2017.1348876 9. International Academy for CPD Accreditation: Consensus Statement for Independence and Funding of Continuing Medical Education (CME)/ Continuing Professional Development Accessed on Jan. 18th, 2018: https://academy4cpdaccreditation.files.wordpress.com/201 8/01/consensus-statement-for-independence-and-funding- of-cme_cpd_final.pdf 10. Daiana Stolz, Reinhard Griebenow, Andre Tichelli, Andrew J. Ullmann, Richard Costello, Lampros Michalis, Margarita Guenova, Sandy Sutter, Fabiola De Andrade & Robert Schaefer (2017) Position paper on current aspects of sponsoring in accredited CME, Journal of European CME, 6:1, 1312062, DOI: 10.1080/21614083.2017.1312062 11. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group Accessed on Jan. 18th, 2018: http://www.gradeworkinggroup.org 12. Cochrane Library Accessed on Jan. 18th, 2018: http://www.cochranelibrary.com 13. Katz HP, Goldfinger SE, Fletcher SW. Academia-industry collaboration in continuing medical education: description of two approaches. J Contin Educ Health Prof. 2002;22(1):43–54. 14. Gesetz zur Bekämpfung von Korruption im Gesundheitswesen (Law against corruption in the health- care system) Accessed on Jan. 18th, 2018: https://www.bmjv.de/SharedDocs/Gesetzgebungsverfahren /Dokumente/BGBl_Bekaempfung_Korruption_Gesundheitsw esen.pdf?__blob=publicationFile&v=3
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel